Madrigal faces financial challenges and competition for Rezdiffra. Read more to understand why MDGL stock is downgraded from ...

Dupixent (dupilumab) is tipped to be the market ... Sanofi says there has been more than 200 applications to receive the drug under the system, which ceases once a drug gains marketing approval.

Diana Taurasi is still mulling over her decision whether to play another season in the WNBA or retire. The 20-year veteran ...

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, drug pipeline outlook, the ...

Mike Sorrentino is a Senior Editor for Mobile, covering phones, texting apps and smartwatches -- obsessing about how we can make the most of them. Mike also keeps an eye out on the movie and toy ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Immunology drug Dupixent is seeing very strong, steady growth in atopic dermatitis and asthma, and approvals continue to expend to new indications (nasal polyposis) and younger patients.

Sanofi and Regeneron’s immunology juggernaut Dupixent is on the brink of another big new indication after it was recommended by the EMA’s human medicines committee for chronic obstructive ...

The Billboard 200 is the United States’ main albums chart, compiled by Billboard magazine based on sales and streams in the USA. View the full Billboard 200 here.

What does Nifty 200 represent? Represents the performance of 200 large-cap and mid-cap companies listed on the National Stock Exchange (NSE), providing a broader market coverage beyond the Nifty 50..

Price: Bajaj Pulsar RS 200 price for its variant - Pulsar RS 200 Standard starts at Rs. 1,72,698. The mentioned Pulsar RS 200 price is the average ex-showroom. Bajaj Pulsar RS 200 is a sports bike ...

Honor has been spreading its wings in India with a slew of launches. The company recently introduced the Honor 200 series in the country to expand its portfolio in the mid-range and premium segments.